What is the recommended dosage of triclofos (sedative) for treating insomnia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Triclofos Dosage for Insomnia Treatment

For adults with insomnia, the recommended dosage of triclofos is 2 to 3 sprays orally, three times daily, while children under twelve should receive half the adult dosage. 1

Dosage Guidelines

  • Adults: 2-3 sprays orally, three times daily
  • Children under 12: Half the adult dosage (1-1.5 sprays, three times daily)
  • Administration timing: Do not take within 15 minutes of consuming food, beverage, or brushing teeth
  • Pediatric use: Consult a physician before using in children under 12 years of age

Efficacy and Placement in Treatment Algorithm

Triclofos is not specifically mentioned in the American Academy of Sleep Medicine's clinical practice guidelines for the pharmacologic treatment of chronic insomnia in adults 2. According to these guidelines, the following medications are recommended for insomnia treatment:

  1. First-line options (suggested by guidelines):

    • Suvorexant for sleep maintenance insomnia
    • Eszopiclone for sleep onset and maintenance insomnia
    • Zolpidem for sleep onset and maintenance insomnia
    • Temazepam for sleep onset and maintenance insomnia
    • Doxepin for sleep maintenance insomnia
  2. Not recommended by guidelines:

    • Trazodone
    • Tiagabine
    • Diphenhydramine
    • Melatonin
    • L-tryptophan
    • Valerian

Clinical Considerations

Patient Selection

When considering triclofos for insomnia treatment, prioritize:

  • Patients who have not responded to first-line agents
  • Patients who cannot tolerate recommended medications
  • Short-term use only due to limited evidence for long-term safety

Monitoring and Follow-up

  • Follow up within 2-4 weeks of initiating treatment to assess:
    • Frequency and severity of insomnia symptoms
    • Daytime functioning
    • Medication side effects
    • Need for treatment plan adjustments 3

Important Precautions

  • Take medication at consistent times each day to maintain steady blood levels
  • Monitor for next-day somnolence, which is a common side effect with sedative medications
  • Consider using standardized sleep assessment tools (e.g., Insomnia Severity Index) to track progress

Alternative Options

If triclofos is not appropriate or effective, consider these evidence-based alternatives:

  • Non-pharmacological approaches (first-line per guidelines):

    • Cognitive behavioral therapy for insomnia (CBT-I)
    • Consistent sleep schedule
    • Limiting daytime napping to 30 minutes maximum and not after 2pm
    • Avoiding caffeine, nicotine, and alcohol
    • Using the bedroom only for sleep and sex 3
  • Pharmacological alternatives:

    • Low-dose doxepin (3-6 mg) for sleep maintenance insomnia 2
    • Zolpidem (10 mg) for sleep onset and maintenance insomnia 2
    • Temazepam (15 mg) for sleep onset and maintenance insomnia 2

Caution

Triclofos is not included in the American Academy of Sleep Medicine's clinical practice guidelines for insomnia treatment, suggesting limited evidence for its efficacy compared to recommended alternatives. When prescribing any sedative medication, always consider the risk-benefit ratio, particularly regarding potential for dependence, tolerance, and adverse effects on daytime functioning.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Sleep Disorders Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.